Mr Wong is a corporate adviser and investment banker with more than 28 years in the finance industry and brings his experience and expertise to the Board of Prima.Formerly a stockbroker for 21 years, Mr Wong was admitted as a Member of the Australian Stock Exchange in 1988 and was the principal of Intersuisse Limited until 1995 when he established and listed on ASX the Barton Capital group of companies including eStar Online.Mr Wong was also a founding Director of both Pluton Resources Limited and Gujarat NRE Resources NL.

He is also involved in a number of philanthropic activities, these include current directorships on UNSW Foundation Limited, Ian Thorpe�s Fountain for Youth Foundation, Honorary Life Governor of the Science Foundation for Physics at the University of Sydney.Mr Wong remains a Fellow of the Financial Services Institute of Australasia, he is a Practitioner Member (Master Stockbroking) of the Stockbrokers Association of Australia and a Fellow of the Australian Institute of Company Directors.Mr Wong was appointed to the Board on April 28th 2010.

Mr Rogers, has a strong science and corporate consultancy background with his focus being on the incubation of business ideas and the establishment of both internal ventures and external partnerships, including finance concept origination for the likes of Macquarie Bank. Mr Rogers was appointed to the Board on 16 October, 2007.

Dr Hammel is a partner with ProPharma International Partners, a pharmaceutical/biotechnology consulting firm providing a range of business, financial and product development services. He has previously held senior management positions with Glaxo Smith Kline, Connetics Corporation (Vice President for Commercial Development), Matrix Pharmaceuticals Inc. (Vice President Business Development, Sales and Marketing) and has also held several positions at Glaxo Inc, where he has been  Director, Professional Affairs; Director, New Business Development; and Director, Marketing Services.